- Home
- NMI vs ARAY Comparison
NMI vs ARAY Comparison
Compare NMI & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMI | ARAY |
|---|---|---|
| Founded | 1988 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.4M | 100.5M |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | NMI | ARAY |
|---|---|---|
| Price | $9.95 | $0.83 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | 28.4K | ★ 826.4K |
| Earning Date | 01-01-0001 | 02-04-2026 |
| Dividend Yield | ★ 4.10% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $450,902,000.00 |
| Revenue This Year | N/A | $3.82 |
| Revenue Next Year | N/A | $4.08 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.51 |
| 52 Week Low | $8.30 | $0.78 |
| 52 Week High | $10.05 | $2.95 |
Technical Indicators
Market Signals| Indicator | NMI | ARAY |
|---|---|---|
| Relative Strength Index (RSI) | 41.76 | 38.10 |
| Support Level | $9.99 | $0.79 |
| Resistance Level | $10.28 | $0.88 |
| Average True Range (ATR) | 0.14 | 0.05 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 2.38 | 25.82 |
Price Performance
Historical ComparisonAbout NMI Nuveen Municipal Income Fund Inc.
Nuveen Municipal Income Fund Inc is a diversified, closed-end management investment company. The Fund's investment objective is to provide a high level of current income exempt from federal income tax, which it seeks to achieve by investing mainly in a diversified portfolio of tax-exempt municipal obligations.
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.